While rare, diabetic ketoacidosis occurs overwhelmingly in patients taking SGLT2 inhibitors with type 2 diabetes, according to the analysis from 3 North Carolina medical schools. A data analysis in ...
A case series detailing the association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and a serious side effect of euglycemic diabetic ketoacidosis (DKA) in nine patients, seven of whom ...
The American Diabetes Association (ADA) defines DKA as a combination of hyperglycemia with a blood glucose ≥250 mg/dL, a metabolic acidosis with bicarbonate ≤18 mEq/L, an anion gap >10, and arterial ...
Diabetic ketoacidosis is a life-threatening complication of diabetes that occurs when the body breaks down fats too quickly. Diabetic ketoacidosis (DKA) occurs in people with diabetes when the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback